Certified by Founder Lodge
Boehringer Ingelheim
Germany - Ingelheim am Rhein, Rhineland-Palatinate
INVESTOR
1 Disclosed Funding Rounds $5,198,000
6 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates
| Company | Date | Round | Raised |
|---|---|---|---|
 C-mo Medical Solutions |
January, 31 ,2023 | Seed | $5,198,000 |
 DiogenX |
May, 11 ,2023 | Series A | $30,056,125 |
 Otto |
September, 01 ,2023 | Series B | $43,000,000 |
 Actym Therapeutics, Inc. |
October, 20 ,2023 | Series A | $59,500,000 |
 GLOX Therapeutics Ltd. |
November, 15 ,2023 | Unknown | $5,362,000 |
 Tacalyx GmbH |
April, 30 ,2026 | Seed | $12,843,270 |
Truemeds India
Receptor Life Sciences, Inc.
Koneksa
MAYD: MEDS AT YOUR DOORSTEP
Fullife Healthcare Pvt. Ltd.
Jupid | $840,000 | (May 1, 2026)
DISA Technologies, Inc. | $33,000,000 | (May 1, 2026)
Blomma | $5,000,000 | (May 1, 2026)
Illuminant Surgical | $8,400,000 | (May 1, 2026)
Dreambase | $3,700,000 | (May 1, 2026)
